
Ralph J. Gitomer
Examiner (ID: 10080, Phone: (571)272-0916 , Office: P/1657 )
| Most Active Art Unit | 1657 |
| Art Unit(s) | 1803, 2899, 1651, 1657, 1815, 1655, 1627, 1623, 1622, 1211 |
| Total Applications | 3335 |
| Issued Applications | 2109 |
| Pending Applications | 286 |
| Abandoned Applications | 943 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4688971
[patent_doc_number] => 20080033152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Three-Phase Partitioning Method for Purifying a Protein'
[patent_app_type] => utility
[patent_app_number] => 11/832830
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4516
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20080033152.pdf
[firstpage_image] =>[orig_patent_app_number] => 11832830
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/832830 | Three-phase partitioning method for purifying a protein | Aug 1, 2007 | Issued |
Array
(
[id] => 5120577
[patent_doc_number] => 20070142292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'COMPOSITION OF LACTOFERRIN RELATED PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/677796
[patent_app_country] => US
[patent_app_date] => 2007-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 43570
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142292.pdf
[firstpage_image] =>[orig_patent_app_number] => 11677796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/677796 | Composition of lactoferrin related peptides and uses thereof | Feb 21, 2007 | Issued |
Array
(
[id] => 4938832
[patent_doc_number] => 20080076151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Compositions for controlling hair growth'
[patent_app_type] => utility
[patent_app_number] => 11/709074
[patent_app_country] => US
[patent_app_date] => 2007-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 28853
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076151.pdf
[firstpage_image] =>[orig_patent_app_number] => 11709074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/709074 | Compositions for controlling hair growth | Feb 20, 2007 | Issued |
Array
(
[id] => 5242237
[patent_doc_number] => 20070020732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Mast cell-specific signal transducer and cDNA thereof'
[patent_app_type] => utility
[patent_app_number] => 11/529217
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3437
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020732.pdf
[firstpage_image] =>[orig_patent_app_number] => 11529217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/529217 | Mast cell-specific signal transducer and cDNA thereof | Sep 28, 2006 | Issued |
Array
(
[id] => 5241759
[patent_doc_number] => 20070020251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Paralytic peptide for use in neuromuscular therapy'
[patent_app_type] => utility
[patent_app_number] => 11/507128
[patent_app_country] => US
[patent_app_date] => 2006-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11655
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11507128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/507128 | Paralytic peptide for use in neuromuscular therapy | Aug 20, 2006 | Issued |
Array
(
[id] => 5834671
[patent_doc_number] => 20060246502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Rabconnectin-3-binding protein'
[patent_app_type] => utility
[patent_app_number] => 11/483356
[patent_app_country] => US
[patent_app_date] => 2006-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16205
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246502.pdf
[firstpage_image] =>[orig_patent_app_number] => 11483356
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/483356 | Rabconnectin-3-binding protein | Jul 6, 2006 | Issued |
Array
(
[id] => 5732383
[patent_doc_number] => 20060257500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'TRPC6 involved in glomerulonephritis'
[patent_app_type] => utility
[patent_app_number] => 11/417113
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 8341
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11417113
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/417113 | TRPC6 involved in glomerulonephritis | May 3, 2006 | Abandoned |
Array
(
[id] => 5678538
[patent_doc_number] => 20060183894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors'
[patent_app_type] => utility
[patent_app_number] => 11/410777
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 7142
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183894.pdf
[firstpage_image] =>[orig_patent_app_number] => 11410777
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/410777 | Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors | Apr 24, 2006 | Abandoned |
Array
(
[id] => 5596209
[patent_doc_number] => 20060160126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => '90 human secreted proteins'
[patent_app_type] => utility
[patent_app_number] => 11/375414
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 197317
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160126.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375414
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375414 | 90 human secreted proteins | Mar 14, 2006 | Abandoned |
Array
(
[id] => 5694971
[patent_doc_number] => 20060155118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Affinity purification system using troponin molecules as affinity ligands'
[patent_app_type] => utility
[patent_app_number] => 11/369285
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18336
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20060155118.pdf
[firstpage_image] =>[orig_patent_app_number] => 11369285
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/369285 | Affinity purification system using troponin molecules as affinity ligands | Mar 5, 2006 | Abandoned |
Array
(
[id] => 466945
[patent_doc_number] => 07235385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-26
[patent_title] => 'Methods for enhancing expression of recombinant proteins'
[patent_app_type] => utility
[patent_app_number] => 11/358581
[patent_app_country] => US
[patent_app_date] => 2006-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9698
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/235/07235385.pdf
[firstpage_image] =>[orig_patent_app_number] => 11358581
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/358581 | Methods for enhancing expression of recombinant proteins | Feb 20, 2006 | Issued |
| 11/341482 | Complex for serving diabetics to reduce the concentration of blood glucose | Jan 29, 2006 | Abandoned |
Array
(
[id] => 418912
[patent_doc_number] => 07276584
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-10-02
[patent_title] => 'Isolated nucleic acid molecules encoding the Br2 P-glycoprotein of maize and methods of modifying growth in plants transformed therewith'
[patent_app_type] => utility
[patent_app_number] => 11/338199
[patent_app_country] => US
[patent_app_date] => 2006-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19038
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276584.pdf
[firstpage_image] =>[orig_patent_app_number] => 11338199
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/338199 | Isolated nucleic acid molecules encoding the Br2 P-glycoprotein of maize and methods of modifying growth in plants transformed therewith | Jan 23, 2006 | Issued |
Array
(
[id] => 5596235
[patent_doc_number] => 20060160152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Purified Stat proteins and methods of purifying thereof'
[patent_app_type] => utility
[patent_app_number] => 11/335005
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 28982
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160152.pdf
[firstpage_image] =>[orig_patent_app_number] => 11335005
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/335005 | Purified Stat proteins and methods of purifying thereof | Jan 18, 2006 | Issued |
Array
(
[id] => 5733727
[patent_doc_number] => 20060258844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Algae fluorescence protein dry powder structure and manufacturing method thereof'
[patent_app_type] => utility
[patent_app_number] => 11/328193
[patent_app_country] => US
[patent_app_date] => 2006-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1339
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258844.pdf
[firstpage_image] =>[orig_patent_app_number] => 11328193
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/328193 | Algae fluorescence protein dry powder structure and manufacturing method thereof | Jan 9, 2006 | Abandoned |
Array
(
[id] => 463014
[patent_doc_number] => 07238498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'Screening methods'
[patent_app_type] => utility
[patent_app_number] => 11/306504
[patent_app_country] => US
[patent_app_date] => 2005-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6129
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/238/07238498.pdf
[firstpage_image] =>[orig_patent_app_number] => 11306504
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/306504 | Screening methods | Dec 29, 2005 | Issued |
| 11/315810 | Method for treating obesity with zinc-charged polypeptides | Dec 21, 2005 | Abandoned |
Array
(
[id] => 668517
[patent_doc_number] => 07094758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-22
[patent_title] => 'Apoptotic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/294968
[patent_app_country] => US
[patent_app_date] => 2005-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14130
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094758.pdf
[firstpage_image] =>[orig_patent_app_number] => 11294968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/294968 | Apoptotic compounds | Dec 4, 2005 | Issued |
Array
(
[id] => 5844930
[patent_doc_number] => 20060122376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Protein complexes having factor VIII:C activity and production thereof'
[patent_app_type] => utility
[patent_app_number] => 11/290051
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14884
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122376.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290051
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290051 | Protein complexes having factor VIII:C activity and production thereof | Nov 29, 2005 | Abandoned |
Array
(
[id] => 5716085
[patent_doc_number] => 20060079448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Compounds and methods for increasing neurogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/288495
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23943
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079448.pdf
[firstpage_image] =>[orig_patent_app_number] => 11288495
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/288495 | Compounds and methods for increasing neurogenesis | Nov 27, 2005 | Abandoned |